Magnetic Resonance Imaging–guided Active Surveillance of Prostate Cancer: Time to Say Goodbye to Protocol-based Biopsies

Magnetic Resonance Imaging–guided Active Surveillance of Prostate Cancer: Time to Say Goodbye to Protocol-based Biopsies

Traditional protocols for active surveillance (AS) are commonly based on digital rectal examination, prostate-specific antigen (PSA), and standard transrectal biopsy, meaning that initial classification errors and inaccurate lesion monitoring can occur. Protocol-based biopsies are performed to asses...

Full description

Bibliographic Details
Main Authors:	Francesco Giganti, Vasilis Stavrinides, Caroline M. Moore
Format:	Article
Language:	English
Published:	Elsevier 2022-04-01
Series:	European Urology Open Science
Subjects:	Prostate magnetic resonance imaging Active surveillance Prostate biopsy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168322000179

Similar Items

Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer
by: Darian Andreas, et al.
Published: (2016-07-01)

Preoperative prostate biopsy and multiparametric magnetic resonance imaging: reliability in detecting prostate cancer
by: Francesco Porpiglia, et al.
Published: (2015-02-01)

Conﬁrmatory transperineal saturation prostate biopsy combined with mpMRI decrease the reclassiﬁcation rate in men enrolled in Active Surveillance: Our experience in 100 men submitted to eight-years scheduled biopsy
by: Pietro Pepe, et al.
Published: (2022-09-01)

Pathological issues in biopsy specimens of men with prostate cancer eligible for active surveillance
by: Roberta Mazzucchelli, et al.
Published: (2014-12-01)

Micro-ultrasound Versus Magnetic Resonance Imaging in Prostate Cancer Active Surveillance
by: Patrick Albers, et al.
Published: (2022-12-01)

Routine systematic prostate biopsies not replaced by magnetic resonance imaging-targeted biopsy
by: David Gómez-Ortiz, et al.
Published: (2022-10-01)

Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy
by: Pietro Pepe, et al.
Published: (2016-12-01)

Reliability of Multiparametric Magnetic Resonance Imaging in Patients with a Previous Negative Biopsy: Comparison with Biopsy-Naïve Patients in the Detection of Clinically Significant Prostate Cancer
by: Biagio Barone, et al.
Published: (2023-06-01)

A review of transrectal ultrasound guided prostate biopsies: Is there still a role for finger guided prostate biopsies?
by: K.S. Jehle, et al.
Published: (2015-03-01)

The Added Value of Systematic Sampling in In-Bore Magnetic Resonance Imaging-Guided Prostate Biopsy
by: Alon Lazarovich, et al.
Published: (2023-09-01)

Diagnostic Value of Cognitive-Registration Multiparametric Magnetic Resonance Guided Biopsy for the Detection of Prostate Cancer after Initial Negative Biopsy
by: Igor Tomašković, et al.
Published: (2018-01-01)

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
by: Muhsin Balaban, et al.
Published: (2019-01-01)

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
by: Nicolette G. Alkema, et al.
Published: (2022-10-01)

MR-Guided Targeted Prostate Biopsy from Radiologists’ Perspective
by: So-Yeon Kim, et al.
Published: (2023-11-01)

Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy
by: Shuanbao Yu, et al.
Published: (2020-11-01)

Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer
by: Jesse D Le, et al.
Published: (2014-08-01)

Impact of bilateral biopsy-detected prostate cancer on an active surveillance population
by: Jonathan H. Wang, et al.
Published: (2019-04-01)

Experience in the use of MRI-ultrasound fusion-targeted biopsy of the prostate for the diagnosis of prostate cancer
by: E. S. Nevirovich, et al.
Published: (2018-10-01)

PROSTATE BIOPSY UNDER MAGNETIC RESONANCE IMAGING GUIDANCE
by: V. I. Kuplevatskiy, et al.
Published: (2016-05-01)

The urologist’s learning curve of “in-bore” magnetic resonance-guided prostate biopsy
by: Barak Rosenzweig, et al.
Published: (2021-12-01)

Prostate health index can stratify patients with Prostate Imaging Reporting and Data System score 3 lesions on magnetic resonance imaging to reduce prostate biopsies
by: John Shung-Lai Leung, et al.
Published: (2024-01-01)

Office-based Magnetic Resonance Imaging–guided Transperineal Prostate Biopsy Without Antibiotic Prophylaxis: A Real-world Clinical Utility Study
by: Lars Boesen, et al.
Published: (2024-01-01)

COMPARISON BETWEEN TRANSRECTAL ULTRASONOGRAPHY GUIDED TRANSRECTAL PROSTATE BIOPSY AND TRANSRECTAL ULTRASONOGRAPHY GUIDED TRANSPERINEAL PROSTATE BIOPSY
by: Randa Halfian, et al.
Published: (2019-07-01)

A multicentre parallel-group randomised trial assessing multiparametric MRI characterisation and image-guided biopsy of prostate in men suspected of having prostate cancer: MULTIPROS study protocol
by: Magdalena Szewczyk-Bieda, et al.
Published: (2019-11-01)

Combination of multiparametric magnetic resonance imaging and transperineal template-guided mapping prostate biopsy to determine potential candidates for focal therapy
by: Young Hyo Choi, et al.
Published: (2023-06-01)

Lesion location agreement between prostatic multiparametric magnetic resonance, cognitive fusion biopsy and radical prostatectomy piece
by: Mario Lourenço, et al.
Published: (2020-01-01)

Transperineal ultrasound-guided prostate biopsy: what the radiologist needs to know
by: Jack Power, et al.
Published: (2022-04-01)

Impact of Ultrasonographic Findings on Cancer Detection Rate during Magnetic Resonance Image/ Ultrasonography Fusion-Targeted Prostate Biopsy
by: Jong Kil Nam, et al.
Published: (2023-07-01)

Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
by: Abdullah Demirtaş, et al.

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

MRI-guided biopsies and minimally invasive therapy for prostate cancer
by: Sangeet Ghai, et al.
Published: (2015-01-01)

Rebiopsy rate after transperineal or transrectal prostate biopsy
by: Jose L. Marenco Jimenez, et al.
Published: (2021-06-01)

Magnetic Resonance Imaging-guided Active Surveillance Without Annual Rebiopsy in Patients with Grade Group 1 or 2 Prostate Cancer: The Prospective PROMM-AS Study
by: Birte Valentin, et al.
Published: (2024-01-01)

Can we improve the detection rate of prostate cancer using standard 12‐core TRUS‐guided prostate biopsy? Focused on the location of prostate biopsy
by: Sangjun Yoo, et al.
Published: (2020-06-01)

Utilization of Multiparametric MRI of Prostate in Patients under Consideration for or Already in Active Surveillance: Correlation with Imaging Guided Target Biopsy
by: Jinxing Yu, et al.
Published: (2020-06-01)

Multiparametric magnetic resonance imaging and clinical variables: Which is the best combination to predict reclassification in active surveillance patients?
by: Marco Roscigno, et al.
Published: (2020-12-01)

The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector
by: Grzegorz Rempega, et al.
Published: (2023-02-01)

Morbidity following transperineal prostate biopsy: Our experience in 8.500 men
by: Pietro Pepe, et al.
Published: (2022-06-01)

Prostate cancer detection using multiparametric 3 – tesla MRI and fusion biopsy: preliminary results
by: Thais Caldara Mussi, et al.

Repeated biopsy in the detection of prostate cancer: When and how many cores
by: Vincenzo Scattoni, et al.
Published: (2014-12-01)